Investor Relations
As an eco-friendly biotechnology company ATS is strategically positioned to develop and commercialize sustainable solutions that answer unmet treatment needs within the pain and inflammation management markets. Additionally, its hydrogel technology has offered ATS Biotech with a wide array of pipeline products that can either be used within the healthcare sector or integrated into other consumer products. This plasticity enables ATS to deliver to dynamic global markets while maintaining a central focus: hydrogels.
ATS Biotech as a development and commercialization company is founded upon a strong global network of business and scientific expertise. It is this foundation that has contributed to the successful development of ATS Biotech's two proprietary hydrogels and the growth of the company since its inception in 2005. ATS envisions itself as becoming a global leader within the pain management field offering consumers cost effective, sustainable solutions that can be used by anyone.
For information on Investment and partnership opportunities please Contact Us.